Radioimmunoassay of apolipoprotein a-ii.
Author(s) -
MingShyan Lin,
Paul Garner,
L. Omar Henderson,
Peter N. Herbert
Publication year - 1982
Publication title -
arteriosclerosis an official journal of the american heart association inc
Language(s) - English
Resource type - Journals
eISSN - 2330-9180
pISSN - 0276-5047
DOI - 10.1161/01.atv.2.2.160
Subject(s) - radioimmunoassay , apolipoprotein b , chemistry , population , dilution , cholesterol , antiserum , medicine , endocrinology , antibody , chromatography , biochemistry , biology , immunology , physics , environmental health , thermodynamics
A double antibody radioimmunoassay was developed for apolipoprotein A-II (apo A-II), one of the two major apoproteins of human high density lipoproteins (HDL). Apo A-II contains two identical polypeptide chains linked by a disulfide bond. A specific antiserum was raised in sheep. Tracer apo A-II was radiolabeled with 125I by the Bolton-Hunter technique. Reduction and carboxymethylation of apo A-II approximately doubled its immunoreactivity. Since normal sera were found to contain small amounts of monomeric apo A-II, this represented one potential source of error in the radioimmunoassay. Inclusion of 0.1 M sodium cholate in the assay system, however, led to identical immunoreactivity of dimeric apo A-II and the reduced and carboxymethylated protein. Radioimmunoassay using sheep anti-apo A-II detected 75% to 85% of the apo A-II contained in serum or HDL. Masked antigenic sites could be exposed by organic solvent extraction or, more simply, by dilution of serum samples in the buffer containing 0.1 M sodium cholate. Serum levels of apo A-II were measured in a population of consecutively and prospectively selected free-living subjects between 30 to 69 years of age. Levels were significantly (p less than 0.005) higher in females (n = 201; 42.0 +/- 10.3 mg/dl) than in males (n = 189; 39.0 +/- 8.4 mg/dl). Serum apo A-II levels correlated significantly with HDL-cholesterol levels but less strongly than apo A-I, the other major HDL apoprotein.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom